A study for evaluating the effect of suppressing of blood glucose level after meals of the intake of food containing HYA on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial

A study for evaluating the effect of suppressing of blood glucose level after meals of the intake of food containing HYA on postprandial hyperglycemia : randomized, placebo-controlled, double blind cross-over trial - A study for evaluating the effect of suppressing of blood glucose level after meals of the intake of food containing HYA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028509

Enrollment

Registered

2017-08-03

Start date

2017-08-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Intake of food without HYA (single ingestion) - washout period - food containing HYA (single ingestion) Intake of food containing HYA (single ingestion) - washout period - food without HYA (single ing

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Males and females from 20 to 69 years of age 2) postprandial blood glucose levels are ranged from 140 mg/dL to 199 mg/dL

Exclusion criteria

Exclusion criteria: 1) Subjects who routinely use health food containing large amount of unsaturated fatty acids or health food for diet 2) Subjects routinely taking medicine or health food which may influence glucose metabolism 3) Subjects who have body mass index (BMI) less than 18.5 kg/square meter or more than 30.0 kg/square meter 4) Subjects who have fasting blood glucose more than 126 mg/dL on preliminary examination 5) Subjects who has under treatment or a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease) 6) Subjects having possibilities for emerging allergy related to the current study 7) Subjects who are under medication or having a history of serious diseases for which medication was required 8) Subjects who are judged as unsuitable for the current study based on the results of clinical and physical preliminary examination 9) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study 10) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating 11) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire 12) Subjects judged as unsuitable for the study by the investigator for other reasons

Design outcomes

Primary

Measure	Time frame
Area under the curve of plasma glucose levels	—

Secondary

Measure	Time frame
Postprandial blood glucose, maximum plasma glucose levels, postprandial insulin levels	—

Countries

Japan

Contacts

Public ContactShinsuke Tsuji

TTC Co., Ltd. Clinical Research Planning Department

s.tsuji@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026